Impact of PPIs on patient focused symptomatology in GERD

References

• AchimARiddermannTPfaffenbergerB2005Pantoprazole 40 mg is at least comparable to esomeprazole 40 mg in achieving endoscopically confirmed healing and symptom relief of gastroesophageal reflux disease (GERD) after 4, 8 and 12 weeks of treatmentCan J Gastroenterol19Suppl CDR.0038
   Google Scholar
• AchimARiddermannTBethkeTD2005A new integrated approach for assessing the effectiveness of pantoprazole and esomeprazole treatment in patients with gastroesophageal reflux disease (GERD)Gastroenterology4Suppl 2A528
   Google Scholar
• ArmstrongDMonnikesHBardhanKD2004The construction of a new evaluative GERD questionnaire – methods and state of the artDigestion7071815334021
   PubMed Web of Science ®Google Scholar
• BardhanKAchimARiddermannT2005Achieving complete remission in patients with erosive gastroesophageal reflux disease (GERD): pantoprazole is comparable with esomeprazoleGut54Suppl VIIA106
   Google Scholar
• BardhanKDAchimARiddermannT2007A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving ‘complete remission’ in gastro-oesophageal reflux diseaseAliment Pharmacol Ther251461917539986
   PubMed Web of Science ®Google Scholar
• BardhanKArmstrongDFassR2005The ReQuest™ LA-classification: a novel integrated approach for the comprehensive assessment of treatment outcome of gastroesophageal reflux disease (GERD)Can J Gastroenterol19Suppl CR.0031
   Google Scholar
• BardhanKDBerghoferP2007Look – but also listen! ReQuest™: An essay on a new validated scale to assess the outcome of GERD treatmentDigestion75Suppl8710017489037
   PubMed Web of Science ®Google Scholar
• BardhanKDStanghelliniVArmstrongD2004aEvaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuestDigestion692293715256829
   PubMed Web of Science ®Google Scholar
• BardhanKDStanghelliniVArmstrongD2004bInternational validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux diseaseAliment Pharmacol Ther20891815479361
   PubMed Web of Science ®Google Scholar
• BeckerlingABraunWSommerM2007Process of measuring in clinical medicine – implications of different definitions in clinical therapeutic studiesDigestion75Suppl 1253117489029
   PubMed Web of Science ®Google Scholar
• CarlssonRDentJWattsR1998Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study GroupEur J Gastroenterol Hepatol10119249581986
   PubMed Web of Science ®Google Scholar
• DeanBBGanoADJrKnightK2004Effectiveness of proton pump inhibitors in nonresponsive reflux diseaseClin Gastroenterol Hepatol26566415290657
   PubMed Web of Science ®Google Scholar
• DentJBrunJFrederickAM1999An evidence-based appraisal of reflux disease management – the Genval Workshop ReportGut44Suppl 2S1S1610741335
   PubMed Web of Science ®Google Scholar
• DentJBrunJFrederickAM2004An evidence-based appraisal of reflux disease: workshop background, processes, terminology, has proved to be a challenging task. Any accurate recommendations and discussion outputsGut53Suppl 4iv12415082609
   PubMedGoogle Scholar
• DentJEl-SeragHBWallanderMA2005Epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut545710715831922
   PubMed Web of Science ®Google Scholar
• DimenasEGliseHHallerbackB1993Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?Scand J Gastroenterol2868178210982
   PubMed Web of Science ®Google Scholar
• DimenasECarlssonGGliseH1996Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal diseaseScand J Gastroenterol Suppl2218139110389
   PubMedGoogle Scholar
• EnckPDuboisDMarquisP1999Quality of life in patients with upper gastrointestinal symptoms: results from Domestic/International Gastroenterology Surveillance Study (DIGEST)Scand J Gastroenterol Suppl231485410565623
   PubMedGoogle Scholar
• FassRFennertyMBVakilN2001Nonerosive reflux disease – current concepts and dilemmasAm J Gastroenterol963031411232668
   PubMed Web of Science ®Google Scholar
• FassRBerghoferPGatzG2005Symptom pattern determines the time to first symptom relief in erosive esophagitis (EE) patients treated with a proton pump inhibitor (PPI)Gut54Suppl VIIA109
   Google Scholar
• FassR2007Erosive esophagitis and nonerosive reflux disease (NERD) – comparison of epidemiologic, physiologic, and therapeutic characteristicsJ Clin Gastroenterol41131717245209
   PubMed Web of Science ®Google Scholar
• FergusonDDDeVaultKRKrishnaM2006Enhanced magnification directed biopsies do not increase the detection of intestinal metaplasia in patients with GERDAm J Gastroenterol1011611616863568
   PubMed Web of Science ®Google Scholar
• Gallup1988A Gallup Organization National Survey: Heartburn Across AmericaPrincetonThe Gallup Organization Inc
   Google Scholar
• GalmicheJPBarthelemyPHamelinB1997Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisaprideAliment Pharmacol Ther11765739305487
   PubMed Web of Science ®Google Scholar
• GalmicheJPLetessierEScarpignatoC1998Treatment of gastro-oesophageal reflux disease in adultsBr Med J316172039614026
   PubMed Web of Science ®Google Scholar
• GillessenASchoffelLNaumburgerA2004Symptomatic relief with pantoprazole 40 mg is significantly faster than with omeprazole 20 mgGut53Suppl VIA103
   Google Scholar
• GlatzelDAbdel-QaderMGatzG2006Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapseDigestion741455417230024
   PubMed Web of Science ®Google Scholar
• GokK-LBenazoumigRSanderP2007Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial- the EMANCIPATE studyEur J Gastroenterol Hepatol192051117301646
   PubMed Web of Science ®Google Scholar
• HeadingRCBardhanKDSanderP2006Application of the complete remission concept: Many patients with GERD are incompletely treated by a standard proton pump inhibitor (PPI) regimeGut55Suppl VA 62
   Google Scholar
• HeadingRCBerghoferPDoerflerH2008Interactions of GERD-related symptoms, Health-related quality of life and anxiety and depression in GERD patients treated with a PPIAm Gastroenterol Assoc
   Google Scholar
• HoltmannG2001Reflux disease: the disorder of the third millenniumEur J Gastroenterol Hepatol13Suppl 1551111204811
   PubMed Web of Science ®Google Scholar
• HoltmannG2005Understanding GERD symptoms in clinical settingDrugs Today (Barc)41Suppl B13716200227
   PubMed Web of Science ®Google Scholar
• IsolauriJLuostarinenMIsolauriE1997Natural course of gastroesophageal reflux disease: 17–22 year follow up of 60 patientsAm J Gastroenterol9237418995934
   PubMed Web of Science ®Google Scholar
• JasaniKPitermanLMcCallL1999Gastroesophageal reflux and quality of life. Patient’s knowledge, attitudes, and perceptionsAust Fam physician28Suppl 1S1589988922
   PubMedGoogle Scholar
• JohanssonKEAskPBoerydB1986Oesophagitis, signs of reflux and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux diseaseScand J Gastroenterol21837473775250
   PubMed Web of Science ®Google Scholar
• JohnsonDAFennertyMB2004Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux diseaseGastroenterology126660414988819
   PubMed Web of Science ®Google Scholar
• JonesRHHunginAPPhillipsJ1995Gastroesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findingsEur J Gen Pract114954
   Google Scholar
• Kaplan-MachlisBSpieglerGERevickiDA1999Health-related quality of life in primary care patients with gastro esophageal reflux diseaseAnn Pharmacother331032610534213
   PubMed Web of Science ®Google Scholar
• KartmanBGatzGJohannessonM2004Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and SwedenMed Decis Making24405215005953
   PubMed Web of Science ®Google Scholar
• KatoMOnoSNakagawaM2007Endoscopic examination including magnifying endoscopy for diagnosis of GERDNippon Rinsho658657117511225
   PubMedGoogle Scholar
• KiesslichRKanzlerSViethM2004Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopyDigestive Diseases22221715383765
   PubMed Web of Science ®Google Scholar
• KlauserAGSchindlebeckNEMüller-LissnerSA1990Symptoms in gastro-oesophageal diseaseLancet33520581967675
   PubMed Web of Science ®Google Scholar
• KleinmanLLeidyNKCrawleyJ2001A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaireMed Care39181911176555
   PubMed Web of Science ®Google Scholar
• KusterERosEToledo-PimentelV1994Predictive factors of the long-term outcome in gastroesophageal reflux disease: six year follow up of 107 patientsGut358148307456
   PubMed Web of Science ®Google Scholar
• LabenzJArnstrongDLauritsenK2006Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance study of healed therapy erosive esophagitis: results from the EXPO studyAliment Pharmacol Ther23449
   Web of Science ®Google Scholar
• LindTHavelundTCarlssonR1997Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic responseScand J Gastroenterol3297499361168
   PubMed Web of Science ®Google Scholar
• LockeGRTalleyNJWeaverAL1994A new questionnaire for gastroesophageal reflux diseaseMayo Clin Proc69539478189759
   PubMed Web of Science ®Google Scholar
• LockeGIIITalleyNJFettSL1997Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, MinnesotaGastroenterology1121448569136821
   PubMed Web of Science ®Google Scholar
• MalfertheinerPFassRQuigleyEM2006Review article: from gastrin to gastro-oesophageal reflux disease – a century of acid suppressionAliment Pharmacol Ther236839016556170
   PubMed Web of Science ®Google Scholar
• ManabeNYoshiharaMSasakiA2002Clinical characteristics and natural history of patients with low-grade reflux esophagitisGastroenterrol Hepatol1794954
   PubMed Web of Science ®Google Scholar
• ModlinIMMalfertheinerPHuntRH2007GERD evaluation: time for a new paradigm?J Clin Gastroenterol412374117426460
   PubMed Web of Science ®Google Scholar
• MonnikesHBardhanKDStanghelliniV2004Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERDDigestion692384415256830
   PubMed Web of Science ®Google Scholar
• MonnikesHPfaffenbergerBGatzG2005Novel measurement of rapid treatment success with ReQuestTM: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazoleDigestion71152815870503
   PubMed Web of Science ®Google Scholar
• MonnikesHBerghoferPGatzG2005First determination of the clinically important difference of ReQuestTM sum scores in patients with erosive gastroesophageal reflux disease (GERD) by comparison of active treatment versus placeboGut54Suppl VIIA108
   Google Scholar
• MonnikesHBardhanKDStranghelliniV2007Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERDDigestion75Suppl 141717489031
   PubMed Web of Science ®Google Scholar
• MonnikesHDoerflerHSchmittH2008Is the response of GERD patients to PPI therapy affected by the presence of IBS-like symptoms?Am Gastroenterol Assoc
   Google Scholar
• NakamuraTShirakawaKMasuyamaH2005Minimal change oesophagitits: a disease with characteristic differences to erosive oesophagitisAliment Pharmacol Ther21192615943842
   PubMed Web of Science ®Google Scholar
• NaumburgerASchoffelLGillessenA2004Comparison of two treatment regimens in symptomatically homogenous GERD patient populations: pantoprazole relieves gastrointestinal symptoms significantly better than omeprazoleGut53Suppl VIA108
   PubMedGoogle Scholar
• NebelOTFornesMFCastellDO1976Symptomatic gastroesophageal reflux: incidence and precipitating factorsAm J Dig Dis219536984016
   PubMedGoogle Scholar
• OfmanJJDornGHFennertyMB2002The clinical and economic impact of competing management strategies for gastro-oesophageal reflux diseaseAliment Pharmacol Ther162617311860409
   PubMed Web of Science ®Google Scholar
• PaceFBollaniSMolteniP2004Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD) – a reappraisal 10 years onDig Liver Dis36111515002817
   PubMedGoogle Scholar
• ParePArmstorngDPericakDMmath2003Pantoprazole rapidly improves Health-Related Quality of Life in patients with heartburn: a prospective randomized, double blind comparative study with NizatidineJ Clin Gastroenterol37132812869883
   PubMed Web of Science ®Google Scholar
• PrasadMRentzAMRevickiDA2003The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature reviewPharmacoeconomics217699012859219
   PubMed Web of Science ®Google Scholar
• QuigleyEHeadingRMonnikesH2007Exploring the spectrum of GERD: myths and realitiesAnn Gastroenterol2015563
   Google Scholar
• RentzAMBattistaCTrudeauE2001Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studiesPharmacoeconomics193496311383752
   PubMed Web of Science ®Google Scholar
• RevickiDACrawleyJAZodetMW1999Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux diseaseAilment Pharmacol Ther13162130
   PubMed Web of Science ®Google Scholar
• RichterJECampbellDRKahrilasPJ2000Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux diseaseArch Intern Med1601803910871974
   PubMed Web of Science ®Google Scholar
• RonkainenJAroPStorskrubbT2005High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study reportScand J Gastroenterol402758515932168
   PubMed Web of Science ®Google Scholar
• RothmanMFarupCStewartW2001Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trialsDig Dis Sci461540911478508
   PubMed Web of Science ®Google Scholar
• RubinGUebelPBrimo-HayekA2008Validation of a brief symptom questionnaire (ReQuest in Practice™) for patients with gastroesophageal reflux disease (GERD)Aliment Pharmacol Ther278465118266995
   PubMed Web of Science ®Google Scholar
• RuigomezAGarcia RodriguezLAWallanderMA2004Natural history of gastro-oesophageal reflux disease diagnosed in general practiceAliment Pharmacol Ther207516015379835
   PubMed Web of Science ®Google Scholar
• SchoffelLNaumburgerAGillessenA2004Pantoprazole is significantly more effective in relieving GERD-associated sleep disturbances than omeprazoleGut53Suppl VIA107
   Google Scholar
• ScholtenS2007Long-term management of gastroesophageal reflux disease with pantoprazoleTher Clin Risk Manag32314318360632
   PubMedGoogle Scholar
• SontagSJSonnennbergASchnellTG2006The long-term natural history of gastroesophageal reflux diseaseJ Clin Gastroenterol4039840416721220
   PubMed Web of Science ®Google Scholar
• StanghelliniV2004ReQuest – the challenge of quantifying both esophageal and extra-esophageal manifestations of GERDBest Pract Res Clin Gastroenterol18Suppl273015588792
   PubMed Web of Science ®Google Scholar
• StanghelliniVArmstrongDMonnikesH2004Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?Aliment Pharmacol Ther194637914987316
   PubMed Web of Science ®Google Scholar
• StanghelliniVArmstrongDMonnikesH2005Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studiesDigestion711455115870502
   PubMed Web of Science ®Google Scholar
• StanghelliniV2005ReQuest: new dimensions in the assessment and management of GERDDrugs, Today (Barc)41Suppl B71116200226
   PubMed Web of Science ®Google Scholar
• StanghelliVArmstrongDMönnikesH2005Determination of ReQuestTM-based symptom thresholds to define symptom relief in GERD clinical studiesDigestion711455115870502
   PubMed Web of Science ®Google Scholar
• StanghelliniVArmstrongDMonnikesH2006Objective definition of symptom relief in clinical studies: determination of international GERD symptom thresholds based on ReQuestTMGastroenterology130Suppl 2A455
   Google Scholar
• StephensRJHopwoodPGirlingDJ1997Randomized trails with quality of life endpoints: Are doctors’ ratings of patients’ physical symptoms interchangeable with patients’ self-ratings?Qual Life Res6225369226980
   PubMed Web of Science ®Google Scholar
• ThomsonABRBarkunANArmstrongD2003The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET-PE) StudyAliment Pharmacol Ther174819112622756
   PubMed Web of Science ®Google Scholar
• ThomsonAPeterSReQuest is a powerful instrument to differentiate treatment response [abstract]Can J Gastroenterol21Suppl A118A (Abstr 157)
   Google Scholar
• VakilNvan ZantenSVKahrilasP2006The Montreal classification and definition of gastroesophageal reflux disease: a global evidenced-based consensusAm J Gastroenterol10119002016928254
   PubMed Web of Science ®Google Scholar
• Van RensburgCBardhanKTulassayZ2005Pantoprazole 40 mg is comparable to esomeprazole 40 mg for first and sustained symptom relief in patients with erosive gastroesophageal reflux disease (GERD)Gastroenterology128Suppl 2A530
   Google Scholar
• WilklundIBardhanKDMuller-LissnerS1998Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study GroupItal J Gastroenterol Hepatol3019279615259
   PubMed Web of Science ®Google Scholar
• WiklundI2001Quality of life in patients with gastroesophageal reflux diseaseAm J Gastroenterol96Suppl 8S465311510771
   PubMed Web of Science ®Google Scholar
• WintersCJrSpurlingTJChobanianSJ1987Barret’s esophagus: a prevalent, occult complication of gastroesophageal reflux diseaseGastroenterology92118243781178
   PubMed Web of Science ®Google Scholar